Immunocore Holdings plc - stock earnings
IMCR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -33.7 million USD | 134.6 million USD |
2023Q3 | 2.3 million USD | 62.8 million USD |
2023Q2 | -17.8 million USD | 60.3 million USD |
2023Q1 | -20.7 million USD | 55.2 million USD |
2022Q4 | -20.2 million USD | 53.9 million USD |
2022Q3 | 6.9 million USD | 45.8 million USD |
2022Q2 | -7.4 million USD | 38.9 million USD |
2022Q1 | -21.1 million USD | 29.5 million USD |
2021Q4 | -53.3 million USD | 8.9 million USD |
2021Q3 | -40.6 million USD | 8.0 million USD |
2021Q2 | -45.6 million USD | 7.9 million USD |
2021Q1 | -40.0 million USD | 11.4 million USD |
2020Q4 | -25.8 million USD | 10.1 million USD |
2020Q3 | -25.0 million USD | 8.6 million USD |
2020Q2 | -21.3 million USD | 9.7 million USD |
2020Q1 | -23.1 million USD | 10.2 million USD |
2019Q4 | -34.0 million USD | 7.4 million USD |
IMCR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -70.4 million USD | 317.8 million USD |
2022 | -49.9 million USD | 173.9 million USD |
2021 | -177.9 million USD | 35.9 million USD |
2020 | -101.3 million USD | 41.2 million USD |
2019 | -136.3 million USD | 33.7 million USD |
2018 | -90.9 million USD | 30.0 million USD |
2017 | -48.9 million GBP | 14.3 million GBP |
IMCR
Price: $58.46
52 week price:
Earnings Per Share: -1.43 USD
P/E Ratio: -52.59
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 522338
Market Capitalization: 3.2 billion